Tetrahydrocortisol in glaucoma therapy

Details Tetrahydrocortisol in glaucoma therapy Tetrahydrocortisol in glaucoma therapy

1989-08-21

1991-03-05

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514178, 514182, 514913, 514914, A61K 3156

Patent

active

049978268

ABSTRACT:
Pharmaceutical compositions comprising tetrahydrocortisol and method of using same in the control of intraocular pressure are disclosed.

REFERENCES:
patent: 2783226 (1957-02-01), Gould et al.
patent: 4686214 (1987-08-01), Boltralik
patent: 4812448 (1989-03-01), Knepper
patent: 4863912 (1989-09-01), Southren et al.
Chemical Abstracts, vol. 88 (1978); #99603a; Halatek et al.
Chemical Abstracts, vol. 90 (1979); #198072z; Gierkowa et al.

Affiliated with

Also associated with

Rating

Tetrahydrocortisol in glaucoma therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tetrahydrocortisol in glaucoma therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydrocortisol in glaucoma therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-496889